Claims treatment Sample Clauses

Claims treatment. As noted earlier, claims for retrospective eligibility periods are not reflected in the base data.
AutoNDA by SimpleDocs
Claims treatment. On the Effective Date, allowed Claims arising under section 510(b) of the Bankruptcy Code (each, a “510(b) Claim”), if any, shall be cancelled without any distribution, and such holders of 510(b) Claims will receive no recovery. Voting. Impaired. Each holder of a 510(b) Claim will be conclusively deemed to have rejected the Agreed Plan pursuant to section 1126(g) of the Bankruptcy Code. No holder of a 510(b) Claim will be entitled to vote to accept or reject the Agreed Plan.
Claims treatment. No base data adjustment was required for retroactive eligibility.
Claims treatment. Holders of any claim subject to subordination under section 510(b) of the Bankruptcy Code (collectively, “Section 510(b) Claims”) shall receive no recovery or distribution under the Plan. Voting. Impaired. Each holder of a Section 510(b) Claim shall be conclusively deemed to have rejected the Plan pursuant to section 1126(g) of the Bankruptcy Code. Therefore, each holder of a Section 510(b) Claim will not be entitled to vote to accept or reject the Plan.
Claims treatment. Any claim subject to subordination under section 510(b) of the Bankruptcy Code (collectively, the “Section 510(b) Claims”) shall be canceled, released, and extinguished, and holders thereof shall receive no recovery or distribution under the Plan. Voting Status. Impaired; deemed to reject the Plan. Intercompany Claims Treatment. Each Claim held by a Debtor against another Debtor shall, at the Debtors’ discretion, with the reasonable consent of the Requisite Consenting Creditors, either be (a) reinstated as of the Effective Date or (b) cancelled, in which case, no distribution shall be made on account of such Claim. Voting Status. Deemed to reject the Plan or presumed to accept the Plan; not entitled to vote to accept or reject the Plan. Intercompany Interests Treatment. Each Intercompany Interest shall either be (a) reinstated as of the Effective Date or (b) cancelled, in which case no distribution shall be made on account of such Intercompany Interest, in each case as determined by the Debtors with the reasonable consent of the Requisite Consenting Creditors. Voting Status. Deemed to reject the Plan or presumed to accept the Plan; not entitled to vote to accept or reject the Plan. Existing Equity Interests in Cenveo Treatment. All Existing Equity Interests in Cenveo, whether represented by stock, preferred share purchase rights, warrants, options, or otherwise, will be cancelled, released, and extinguished and the holders of such Existing Equity Interests will receive no distribution under the Plan on account thereof. Voting Status. Impaired; deemed to reject the Plan. Discharge, Releases, Exculpation, and Injunction Provisions Releases and Related Provisions The Plan will include discharge, release, exculpation and injunction provisions substantially similar to the provisions set forth on Exhibit 4 attached hereto, in each case, to the maximum extent permitted under applicable law and otherwise acceptable to the Debtors and reasonably acceptable to the Requisite Consenting Creditors.
Claims treatment. Claims for retrospective eligibility periods are reflected in the base data.

Related to Claims treatment

  • Treatment The Asset Representations Reviewer agrees to hold and treat Confidential Information given to it under this Agreement in confidence and under the terms and conditions of this Section 4.08, and will implement and maintain safeguards to further assure the confidentiality of the Confidential Information. The Confidential Information will not, without the prior consent of the Issuer and the Servicer, be disclosed or used by the Asset Representations Reviewer, or its officers, directors, employees, agents, representatives or affiliates, including legal counsel (collectively, the “Information Recipients”) other than for the purposes of performing Reviews of Review Receivables or performing its obligations under this Agreement. The Asset Representations Reviewer agrees that it will not, and will cause its Affiliates to not (i) purchase or sell securities issued by the Seller or its Affiliates or special purpose entities on the basis of Confidential Information or (ii) use the Confidential Information for the preparation of research reports, newsletters or other publications or similar communications.

  • Equal Treatment No consideration shall be offered or paid to any person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered and paid to all the Subscribers and their permitted successors and assigns.

Time is Money Join Law Insider Premium to draft better contracts faster.